Information
Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

© 2006-2015 Gustave Roussy – All rights reserved

ASCO 2019 - Larotrectinib, first targeted therapy for childhood solid tumours, shown to be effective

back to job offer list
back to clinical trials

Chicago, 3 june 2019
ASCO 2019

ASCO 2019
05/31/2019

Gustave Roussy at ASCO 2019

As every year for almost 55 years, the world’s leading cancer experts will meet in Chicago to talk about the latest advances in clinical oncology at the international meeting of the American Society of Clinical Oncology (ASCO).

ASCO 2019: Artificial intelligence can predict the chances of post-treatment fatigue in breast cancer

back to job offer list
back to clinical trials

Chicago, 1st june 2019
ASCO 2019

ASCO 2019 - Prostate cancer: Darolutamide reduces the risk of pain and does not worsen the quality of life in patients treated for prostate cancer

back to job offer list
back to clinical trials

Chicago, 31st may 2019
ASCO 2019

ASCO 2019 - Gustave Roussy's presentations highlights

back to job offer list
back to clinical trials

Villejuif,  29 may 2019

Gustave Roussy presentations at ASCO 2019

As every year for almost 55 years, the world’s leading cancer experts will meet in Chicago to talk about the latest advances in clinical oncology at the international meeting of the American Society of Clinical Oncology (ASCO). Naturally, Gustave Roussy will be one of the best represented institutions at this conference.

ASCO 2019 - Press releases

back to job offer list
back to clinical trials

ASCO 2019

back to job offer list
back to clinical trials

As every year, the world’s leading cancer experts meet in Chicago to talk about the latest advances in clinical oncology at the international meeting of the American Society of Clinical Oncology (ASCO). Naturally, Gustave Roussy is one of the best represented institutions at this conference.

Gilles Vassal

back to job offer list
back to clinical trials

Professeur Gilles Vassal

RHU LUMIERE

back to job offer list
back to clinical trials

RHU LUMIERE

Une Recherche Hospitalo-Universitaire pour étudier le rôle du microbiote intestinal dans la réponse aux immunothérapies anticancéreuses dans les cancers bronchiques.

Séquencer l'ADN à très haut débit
05/24/2019

Les cancers du sein métastatiques sont génétiquement plus complexes

La prestigieuse revue Nature vient de publier les résultats d'une étude majeure démontrant l'évolution génomique du cancer du sein entre le moment où la tumeur est localisée et le stade avancé métastatique et mettant en évidence deux processus responsables de cette évolution.

Pages